Atlantic Health Co.

Medication Guide

Zepbound® (Tirzepatide) for Weight Loss

Zepbound is a newer dual-action medication that targets both GLP-1 and GIP receptors, offering a more advanced approach to medical weight loss. If you are comparing options, explore our GLP-1 guide or take the eligibility assessment.

Not sure which option is right? Compare with Wegovy →

Why patients ask about Zepbound

Four reasons tirzepatide stands out in medical weight loss

Zepbound combines dual-pathway metabolic support with appetite regulation and strong weight-loss potential, making it a leading option for patients exploring provider-guided treatment.

Dual Hormone Action

Targets both GLP-1 and GIP pathways for enhanced metabolic impact.

Reduced Appetite

Helps decrease hunger and cravings throughout the day.

Improved Metabolism

Supports insulin response and blood sugar regulation.

Stronger Weight Loss Potential

May lead to greater weight reduction compared to older GLP-1 options.

How Zepbound Works

Zepbound works by activating both GLP-1 and GIP receptors, enhancing appetite control and metabolic function.

  • Activates GLP-1 and GIP receptors
  • Reduces hunger signals in the brain
  • Slows gastric emptying
  • Improves insulin sensitivity

Expected Results

Clinical trials suggest that tirzepatide may result in significant weight loss, often exceeding traditional GLP-1 medications when combined with lifestyle changes.

Side Effects

  • Nausea
  • Diarrhea or constipation
  • Fatigue
  • Reduced appetite
Full side effects guide →

Who It’s For

  • Adults with BMI ≥30
  • BMI ≥27 with weight-related conditions
  • Patients seeking a more aggressive medical weight-loss option
  • Those who have not responded to other treatments

Cost

Zepbound pricing varies widely depending on insurance coverage. Without coverage, monthly costs can exceed $1,000.

Cost breakdown →

See if Zepbound is right for you

Takes about 2 minutes • No commitment required